[HTML][HTML] National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: III. The 2020 treatment of chronic …
Z DeFilipp, DR Couriel, A Lazaryan, VR Bhatt… - … and cellular therapy, 2021 - Elsevier
Positive results from recent clinical trials have significantly expanded current therapeutic
options for patients with chronic graft-versus-host disease (GVHD). However, new insights
into the associations between clinical characteristics of chronic GVHD, pathophysiologic
mechanisms of disease, and the clinical and biological effects of novel therapeutic agents
are required to allow for a more individualized approach to treatment. The current report is
focused on setting research priorities and direction in the treatment of chronic GVHD …
options for patients with chronic graft-versus-host disease (GVHD). However, new insights
into the associations between clinical characteristics of chronic GVHD, pathophysiologic
mechanisms of disease, and the clinical and biological effects of novel therapeutic agents
are required to allow for a more individualized approach to treatment. The current report is
focused on setting research priorities and direction in the treatment of chronic GVHD …